Terns Pharmaceuticals Inc
NASDAQ:TERN

Watchlist Manager
Terns Pharmaceuticals Inc Logo
Terns Pharmaceuticals Inc
NASDAQ:TERN
Watchlist
Price: 6.53 USD 6.18%
Market Cap: 554.7m USD
Have any thoughts about
Terns Pharmaceuticals Inc?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

TERN Price Targets Summary
Terns Pharmaceuticals Inc

Wall Street analysts forecast TERN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TERN is 19.31 USD with a low forecast of 7.58 USD and a high forecast of 31.5 USD.

TERN Lowest Forecast
Wall Street Target
7.58 USD
16% Upside
TERN Average Forecast
Wall Street Target
19.31 USD
196% Upside
TERN Highest Forecast
Wall Street Target
31.5 USD
382% Upside
Lowest
Price Target
7.58 USD
16% Upside
Average
Price Target
19.31 USD
196% Upside
Highest
Price Target
31.5 USD
382% Upside

TERN Last Price Targets
Terns Pharmaceuticals Inc

The latest public price target was made on Sep 16, 2024 by Etzer Darout from BMO Capital , who expects TERN stock to rise by 298% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Etzer Darout
BMO Capital
26 USD
Upside 298%
2 months ago
Sep 16, 2024
Terns Pharmaceuticals price target raised to $26 from $19 at BMO Capital
TheFly
Graig Suvannavejh
Mizuho Securities
10 USD
Upside 53%
3 months ago
Aug 21, 2024
Mizuho Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
StreetInsider
Etzer Darout
BMO Capital
19 USD
Upside 191%
8 months ago
Mar 15, 2024
Terns Pharmaceuticals (TERN) PT Raised to $19 at BMO Capital
StreetInsider
Etzer Darout
BMO Capital
Price Target 26 USD
Upside/Downside 298%
View Source
Graig Suvannavejh
Mizuho Securities
Price Target 10 USD
Upside/Downside 53%
View Source
Etzer Darout
BMO Capital
Price Target 19 USD
Upside/Downside 191%
View Source
Terns Pharmaceuticals Inc Competitors:
Price Targets
CLSD
Clearside Biomedical Inc
461% Upside
185750
Chong Kun Dang Pharmaceutical Corp
53% Upside
CIPLA
Cipla Ltd
8% Upside
ORCHPHARMA
Orchid Pharma Ltd
2% Downside
CLSD
Clearside Biomedical Inc
461% Upside
185750
Chong Kun Dang Pharmaceutical Corp
53% Upside
CIPLA
Cipla Ltd
8% Upside
ORCHPHARMA
Orchid Pharma Ltd
2% Downside
DRREDDY
Dr Reddy's Laboratories Ltd
12% Upside
O
039200
Oscotec Inc
78% Upside
NWRN
Newron Pharmaceuticals SpA
80% Upside
NEU
Neuren Pharmaceuticals Ltd
109% Upside

Revenue
Forecast

Revenue Estimate
Terns Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Terns Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Terns Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
What are analyst estimates?

See Also

Summary
TERN intrinsic value, competitors valuation, and company profile.
DCF Valuation
TERN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TERN stock valuation using valuation multiples.
Wall Street Estimates
TERN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TERN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TERN's stock price target?
Price Target
19.31 USD

According to Wall Street analysts, the average 1-year price target for TERN is 19.31 USD with a low forecast of 7.58 USD and a high forecast of 31.5 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 204,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.